The Indiana Myeloma Registry
ConditionPlasma Cell Dyscrasias
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIndiana University
About this trial
This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male or female patients ≥ 18 years of age at the time of informed consent
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Smoldering Multiple Myeloma
Multiple Myeloma
Disqualifiers
None
Trial population
Patients disgnosed with one of the following: 1. Monoclonal Gammopathy of Undetermined Significance (MGUS) 2. Smoldering Multiple Myeloma 3. Multiple Myeloma 4. Bony or Soft Tissue Plasmacytoma 5. Primary Amyloidosis
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
This is a non-interventional trial
Other interventionThis is a non-interventional trial
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Create a repository
The primary objective of this study is to provide a mechanism to store comprehensive clinical, genomic, demographic, social, environmental and quality of life data from subjects with plasma cell dyscrasias
Time frame
5 yearsSecondary outcomes
1
Data collection
To collect data related to clonal evolution, tumor microenvironment, clinical outcomes, adverse events, environmental factors and quality of life that will provide the foundation to create hypotheses for future confirmatory studies.
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov